No Clear Evidence FDA Would Reject New Paxil Suicide Warning, Judge Says
CHICAGO — An Illinois federal judge on Feb. 11 said GlaxoSmithKline PLC (GSK) has not presented “clear evidence” that the Food and Drug Administration would have rejected a stronger adult suicide...To view the full article, register now.
Already a subscriber? Click here to view full article